Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;95:191-196

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koskinen, P. K.
Right arrow Articles by Lemstrom, K. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koskinen, P. K.
Right arrow Articles by Lemstrom, K. B.

(Circulation. 1997;95:191-196.)
© 1997 American Heart Association, Inc.


Articles

Adhesion Molecule P-Selectin and Vascular Cell Adhesion Molecule–1 in Enhanced Heart Allograft Arteriosclerosis in the Rat

Petri K. Koskinen, MD, PhD; Karl B. Lemstrom, MD, PhD

the Transplantation Laboratory, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.

Correspondence to Dr Petri Koskinen, Transplantation Laboratory, University of Helsinki, PO Box 21 (Haartmaninkatu 3), FIN-00014, Helsinki, Finland. E-mail petri.koskinen@helsinki.fi.

Background The increase of P-selectin on endothelial cells (EC) overlying human atherosclerotic plaques in classic atherosclerosis was recently established. We have previously shown that vascular cell adhesion molecule–1 (VCAM-1) is extensively expressed on EC of occluded arteries during accelerated transplant arteriosclerosis. In the present study, with the use of rat heart allografts under different doses of cyclosporine A (CsA), we investigated whether the expression of P-selectin is increased during chronic rejection and possibly coexpressed with VCAM-1 on EC.

Methods and Results Rat cardiac allografts from DA donors to WF recipients were used. Without immunosuppression, these allografts show an irreversible rejection 7 days after transplantation. In the acute rejection model, syngeneic and allogeneic grafts were harvested 5 days after transplantation. In the chronic rejection model, allograft recipients received triple-drug immunosuppression, including azathioprine, methylprednisolone, and CsA in different doses. The grafts were removed 3 months after transplantation. During acute rejection, a significant expression of P-selectin (P<.01) and VCAM-1 (P<.05) on microvascular endothelia, but not on arteries, was noticed. During intense chronic rejection (5 mg/kg CsA), arterial EC expressed P-selectin (P<.01) and VCAM-1 (P<.05) extensively. The expression of tumor necrosis factor–{alpha}, a cytokine inducing both P-selectin and VCAM-1 expression, was upregulated in vascular medial cells (P<.05), in intimal cells (P<.01), and in interstitial mononuclear cells (P<.05). Linear regression analysis revealed a significant correlation between arterial P-selectin (P<.01) and VCAM-1 (P<.01) expression and the intensity of intimal thickening. Also, a significant correlation and coexpression of P-selectin and VCAM-1 in epicardial arteries was demonstrated (P<.05).

Conclusions The early expression of P-selectin on microvascular EC during acute rejection may be the basis of cell adhesion and infiltration into the site of inflammation. During chronic rejection, the intensity of arterial intimal thickening was significantly correlated with the intensity of P-selectin expression on EC, in addition to that of previously reported VCAM-1 expression. Thus, P-selectin may have a crucial role in the pathogenesis of chronic rejection in the vascular wall, augmenting the immune-mediated injury against the allograft.


Key Words: transplantation • arteriosclerosis • adhesion molecules




This article has been cited by other articles:


Home page
Circ. Res.Home page
Q. Xu
Stem Cells and Transplant Arteriosclerosis
Circ. Res., May 9, 2008; 102(9): 1011 - 1024.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Izawa, T. Ueno, M. Jurewicz, T. Ito, K. Tanaka, M. Takahashi, U. Ikeda, O. Sobolev, P. Fiorina, R. N. Smith, et al.
Importance of Donor- and Recipient-Derived Selectins in Cardiac Allograft Rejection
J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2929 - 2936.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. Sawada, Y. Mitani, J. Maruyama, B. H. Jiang, Y. Ikeyama, F. A. Dida, H. Yamamoto, K. Imanaka-Yoshida, H. Shimpo, A. Mizoguchi, et al.
A Nuclear Factor-{kappa}B Inhibitor Pyrrolidine Dithiocarbamate Ameliorates Pulmonary Hypertension in Rats
Chest, October 1, 2007; 132(4): 1265 - 1274.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. Abele, M. Weyand, M. Wollin, N. E. Hiemann, F. Harig, T. Fischlein, and S. M. Ensminger
Clopidogrel reduces the development of transplant arteriosclerosis
J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1161 - 1166.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. M. Wildhirt, C. Schulze, N. Conrad, R. Bauernschmitt, R. Lange, and W. von Scheidt
Persistently increased systemic, but not cardiac-specific, adhesion molecule expression and coronary endothelial dysfunction in human cardiac allografts
J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1175 - 1175.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. A. Kelly, J. R. Allport, A. Tsourkas, V. R. Shinde-Patil, L. Josephson, and R. Weissleder
Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle
Circ. Res., February 18, 2005; 96(3): 327 - 336.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Tanaka, R. D. Terry, G. K. Mokhtari, K. Inagaki, T. Koyanagi, T. Kofidis, D. Mochly-Rosen, and R. C. Robbins
Suppression of Graft Coronary Artery Disease by a Brief Treatment With a Selective {epsilon}PKC Activator and a {delta}PKC Inhibitor in Murine Cardiac Allografts
Circulation, September 14, 2004; 110(11_suppl_1): II-194 - II-199.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Okada, C. Y. Wang, D. W. Hwang, T. Sakaguchi, K. E. Olson, Y. Yoshikawa, K. Minamoto, S. P. Mazer, S.-F. Yan, and D. J. Pinsky
Transcriptional Control of Cardiac Allograft Vasculopathy by Early Growth Response Gene-1 (Egr-1)
Circ. Res., July 26, 2002; 91(2): 135 - 142.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. C. Stoica, M. Goddard, and S. R. Large
The endothelium in clinical cardiac transplantation
Ann. Thorac. Surg., March 1, 2002; 73(3): 1002 - 1008.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. K. Sihvola, V. P. Pulkkinen, P. K. Koskinen, and K. B. Lemstrom
Crosstalk of endothelin-1 and platelet-derived growth factor in cardiac allograft arteriosclerosis
J. Am. Coll. Cardiol., February 20, 2002; 39(4): 710 - 717.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Aziz, P. Hasleton, A. W. Hann, N. Yonan, A. Deiraniya, and I. V. Hutchinson
TRANSFORMING GROWTH FACTOR {beta} IN RELATION TO CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION
J. Thorac. Cardiovasc. Surg., April 1, 2000; 119(4): 700 - 708.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Dietrich, Y. Hu, Y. Zou, S. Dirnhofer, R. Kleindienst, G. Wick, and Q. Xu
Mouse Model of Transplant Arteriosclerosis : Role of Intercellular Adhesion Molecule-1
Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 343 - 352.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Sihvola, P. Koskinen, M. Myllarniemi, M. Loubtchenkov, P. Hayry, E. Buchdunger, and K. Lemstrom
Prevention of Cardiac Allograft Arteriosclerosis by Protein Tyrosine Kinase Inhibitor Selective for Platelet-Derived Growth Factor Receptor
Circulation, May 4, 1999; 99(17): 2295 - 2301.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Davi, M. Romano, A. Mezzetti, A. Procopio, S. Iacobelli, T. Antidormi, T. Bucciarelli, P. Alessandrini, F. Cuccurullo, and G. B. Bon
Increased Levels of Soluble P-Selectin in Hypercholesterolemic Patients
Circulation, March 17, 1998; 97(10): 953 - 957.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, M. Poon, and J. T. Willerson
Learning From the Transgenic Mouse : Endothelium, Adhesive Molecules, and Neointimal Formation
Circulation, January 13, 1998; 97(1): 16 - 18.
[Full Text] [PDF]


Home page
CirculationHome page
K. B. Lemstrom and P. K. Koskinen
Expression and Localization of Platelet-Derived Growth Factor Ligand and Receptor Protein During Acute and Chronic Rejection of Rat Cardiac Allografts
Circulation, August 19, 1997; 96(4): 1240 - 1249.
[Abstract] [Full Text]